Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding [Original Research Articles]

Conclusions
Patients with continuous-flow left ventricular assist device receiving secondary prophylaxis with octreotide had a significantly lower GI bleed recurrence compared with historical controls not treated with octreotide. Additional prospective studies are needed to confirm these data.

Source: Circulation: Heart Failure - November 15, 2017 Category: Cardiology Authors: Shah, K. B., Gunda, S., Emani, S., Kanwar, M. K., Uriel, N., Colombo, P. C., Uber, P. A., Sears, M. L., Chuang, J., Farrar, D. J., Brophy, D. F., Smallfield, G. B. Tags: Cardiomyopathy, Cardiovascular Surgery Original Research Articles Source Type: research